Sanofi to buy Blueprint Medicines in deal worth more than $9 billion The French drugmaker will pick up Blueprint’s approved medicine Ayvakit and a number of experimental therapies

https://www.statnews.com/2025/06/02/sanofi-blueprint-immunology-ayvakit-acquisition/